Malathy Shekhar
Affiliations: | Cancer Biology | Wayne State University, Detroit, MI, United States |
Area:
Oncology, Molecular BiologyGoogle:
"Malathy Shekhar"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Elayoubi J, Chi J, Mahmoud AA, et al. (2023) A Review of Endocrine Therapy in Early-stage Breast Cancer: The Journey From Crudeness to Precision. American Journal of Clinical Oncology |
| Haynes BM, Cunningham K, Shekhar MPV. (2022) RAD6 inhibition enhances paclitaxel sensitivity of triple negative breast cancer cells by aggravating mitotic spindle damage. Bmc Cancer. 22: 1073 |
| Uddin MH, Zhou JY, Pimentel J, et al. (2022) Proteomic Analysis Identifies p62/SQSTM1 as a Critical Player in PARP Inhibitor Resistance. Frontiers in Oncology. 12: 908603 |
| Gajan A, Sarma A, Kim S, et al. (2021) Analysis of Adaptive Olaparib Resistance Effects on Cisplatin Sensitivity in Triple Negative Breast Cancer Cells. Frontiers in Oncology. 11: 694793 |
| Gajan A, Sarma A, Kim S, et al. (2021) Analysis of Adaptive Olaparib Resistance Effects on Cisplatin Sensitivity in Triple Negative Breast Cancer Cells Frontiers in Oncology. 11 |
| Haynes B, Gajan A, Nangia-Makker P, et al. (2019) RAD6B is a major mediator of triple negative breast cancer cisplatin resistance: Regulation of translesion synthesis/Fanconi anemia crosstalk and BRCA1 independence. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 165561 |
| Haynes B, Zhang Y, Liu F, et al. (2019) Corrigendum to "Gold nanoparticle conjugated Rad6 inhibitor induces cell death in triple negative breast cancer cells by inducing mitochondrial dysfunction and PARP-1 hyperactivation: Synthesis and characterization" [Nanomedicine 12 (3) (2016), 745-757]. Nanomedicine : Nanotechnology, Biology, and Medicine |
| Haagenson KK, Zhang JW, Xu Z, et al. (2018) Erratum: Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivity. Oncotarget. 9: 35286 |
| Saadat N, Liu F, Haynes B, et al. (2018) Nano-targeted Delivery of Rad6/Translesion Synthesis Inhibitor for Triple Negative Breast Cancer Therapy. Molecular Cancer Therapeutics |
| Haynes B, Sarma A, Nangia-Makker P, et al. (2017) Breast cancer complexity: implications of intratumoral heterogeneity in clinical management. Cancer Metastasis Reviews |